Viable and necrotic tumor assessment from whole slide images of osteosarcoma using machine-learning and deep-learning models
暂无分享,去创建一个
Ovidiu Daescu | Rashika Mishra | Patrick Leavey | Dinesh Rakheja | Anita Sengupta | David Leonard | Harish Babu Arunachalam | Kevin Cederberg | Rami Hallac | O. Daescu | R. Mishra | P. Leavey | D. Rakheja | Anita Sengupta | R. Hallac | D. Leonard | K. Cederberg
[1] Pau-Choo Chung,et al. A Fast Algorithm for Multilevel Thresholding , 2001, J. Inf. Sci. Eng..
[2] Joachim M. Buhmann,et al. Computational Pathology Analysis of Tissue Microarrays Predicts Survival of Renal Clear Cell Carcinoma Patients , 2008, MICCAI.
[3] M. Loh,et al. Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. , 2015, Blood.
[4] Olaf Hellwich,et al. Deep convolutional neural networks for automatic classification of gastric carcinoma using whole slide images in digital histopathology , 2017, Comput. Medical Imaging Graph..
[5] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[6] M. Gebhardt,et al. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee , 2016, Pediatric blood & cancer.
[7] Constantine Katsinis,et al. Large-scale computations on histology images reveal grade-differentiating parameters for breast cancer , 2006, BMC Medical Imaging.
[8] J. Eary,et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography , 2002, Cancer.
[9] Jonathan H. Chen,et al. Machine Learning and Prediction in Medicine - Beyond the Peak of Inflated Expectations. , 2017, The New England journal of medicine.
[10] B. van Ginneken,et al. Deep learning as a tool for increased accuracy and efficiency of histopathological diagnosis , 2016, Scientific Reports.
[11] Johan A. K. Suykens,et al. Least Squares Support Vector Machine Classifiers , 1999, Neural Processing Letters.
[12] J. Ross Quinlan,et al. Induction of Decision Trees , 1986, Machine Learning.
[13] A. Huvos,et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Geoffrey E. Hinton,et al. ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.
[15] Ovidiu Daescu,et al. Histopathological Diagnosis for Viable and Non-viable Tumor Prediction for Osteosarcoma Using Convolutional Neural Network , 2017, ISBRA.
[16] A. Ruifrok,et al. Quantification of histochemical staining by color deconvolution. , 2001, Analytical and quantitative cytology and histology.
[17] Daniel L. Rubin,et al. Automated Grading of Gliomas using Deep Learning in Digital Pathology Images: A modular approach with ensemble of convolutional neural networks , 2015, AMIA.
[18] Yoshua Bengio,et al. Gradient-based learning applied to document recognition , 1998, Proc. IEEE.
[19] Bahram Parvin,et al. When machine vision meets histology: A comparative evaluation of model architecture for classification of histology sections☆ , 2017, Medical Image Anal..
[20] Ce Zhang,et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features , 2016, Nature Communications.
[21] M. Sydes,et al. International collaboration is feasible in trials for rare conditions: the EURAMOS experience. , 2007, Cancer treatment and research.
[22] Yoav Freund,et al. A decision-theoretic generalization of on-line learning and an application to boosting , 1995, EuroCOLT.
[23] Jian Sun,et al. Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).
[24] José Hernández-Orallo,et al. Volume under the ROC Surface for Multi-class Problems , 2003, ECML.
[25] A. Fischer,et al. Hematoxylin and eosin staining of tissue and cell sections. , 2008, CSH protocols.
[26] M. Sydes,et al. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Thomas G. Dietterich. Multiple Classifier Systems , 2000, Lecture Notes in Computer Science.
[28] Ren-Shyan Liu,et al. Comparison Between F‐18‐FDG Positron Emission Tomography and Histology for the Assessment of Tumor Necrosis Rates in Primary Osteosarcoma , 2006, Journal of the Chinese Medical Association : JCMA.
[29] Luca Maria Gambardella,et al. Mitosis Detection in Breast Cancer Histology Images with Deep Neural Networks , 2013, MICCAI.
[30] Hai Su,et al. Region segmentation in histopathological breast cancer images using deep convolutional neural network , 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).
[31] K. S. Hall,et al. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial , 2016, The Lancet. Oncology.
[32] G. Rosen,et al. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. , 1977, Archives of pathology & laboratory medicine.
[33] Qing Ji,et al. Dynamic contrast‐enhanced magnetic resonance imaging as a prognostic factor in predicting event‐free and overall survival in pediatric patients with osteosarcoma , 2012, Cancer.
[34] F. Cabitza,et al. Unintended Consequences of Machine Learning in Medicine , 2017, JAMA.
[35] Junzhou Huang,et al. Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[36] Mathias Langer,et al. Osteosarcoma: Preliminary Results of In Vivo Assessment of Tumor Necrosis After Chemotherapy With Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging , 2006, Investigative radiology.
[37] K. Moon,et al. Inter and intra-observer reliability in histologic evaluation of necrosis rate induced by neo-adjuvant chemotherapy for osteosarcoma , 2017 .
[38] P. Leavey. Biomarker development in osteosarcoma—Is there no longer any utility to tumor necrosis? , 2016, Pediatric blood & cancer.
[39] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[40] S. Ferrari,et al. Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. , 2002, Oncology reports.
[41] Ovidiu Daescu,et al. Computer Aided Image Segmentation and Classification for Viable and Non-Viable Tumor Identification in Osteosarcoma , 2017, PSB.
[42] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.